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ABSTRACT 
The published benefits of polymeric nanoparticles as a system for antioxidant 
delivery have encompassed topics of improved oral delivery, bioavailability, and 
modified release to name a few.    Generally accepted as safe polymers Poly(lactic-co-
glycolic acid) and the mucoadhesive chitosan were selected to entrap alpha-tocopherol 
and lutein.  This study proposed to assess the physical stability of PLGA and Chi/PLGA  
nanoparticles with entrapped bioactives in varying biological suspension medias ( water, 
pbs, hbss and cell media).  Also, to assess the chemical stability of the entrapped 
antioxidants lutein and alpha-tocopherol within the same media as deemed relevant for 
in-vitro and and in-vivo studies.  Of the tested media, physical stability was not media 
dependent for the PLGA(AO) or PLGA/Chi (AO) particles.  Neither the size nor the PDI 
appeared significantly affected by the media it was re-suspended.  Entrapped alpha-
tocopherol remained chemically stable throughout the time suspended in the various 
biological mediums.  While the lutein emulsion stability decreased over time, the NP(L) 
demonstrated improved stability.  Also, the entrapped lutein stability was not dependent 
on the selected medium.  Identifying any potential effects of suspension media on 
polymeric nanoparticles and the entrapped bioactive affords the opportunity to improve 
analysis of more robust or complex nanoparticle studies.  Also, presented are 
considerations that should be taken prior to design of an experiment.   
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CHAPTER 1. INTRODUCTION 
 
1.1 Antioxidants 
 
 Pathophysiology of numerous and diverse degenerative diseases including 
cancer, cardiovascular disease, stroke, Alzheimer’s disease, diabetes and others 
indicates that free radicals are responsible in some form for these diseases (Maulik, G 
et.al. 1998).  Collectively, antioxidants have been shown to protect biological systems 
from these free radicals and their damaging effects (Karadag, A et.al. 2009).  With the 
increased interest in natural antioxidants and their potential for disease prevention, 
consideration has been given to increasing their bioavailability, stability, bioactivity and 
general effectiveness (Hoe Do, J et.al. 2008, Karadag, A et.al 2009, Fang, Z et.al. 
2010).  
 Proficient in protecting biological systems from damaging effects of reactions and 
processes involving reactive oxygen and nitrogen species (ROS and RNS), antioxidants 
have increasingly gained interest within biological, medical, and agrichemical fields.  
These substances prevent or considerably reduce adverse reactive species and human 
physiological functions at lower concentrations relative to oxidizable substrates 
(Karaday, A et.al. 2009).  Antioxidants can act as catalytic systems neutralizing or 
diverting ROS, barriers limiting ROS access to biological sites, or as scavenging chain 
breaking antioxidants that destroy ROS (e.g. ascorbic acid and tocopherols) (Karaday, 
A et.al. 2009).  Due to potential health benefits for humans, research on the application 
of polyphenols (e.g. catechins, isoflavones), hydroxybenzoic acids, vitamin E and other 
antioxidants has recently attracted great interest from the nutrition, foods, and 
pharmaceutical industries. Further attention should be given to vitamin E and Lutein.  
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1.1.1 Vitamin E: Function and Delivery  
 Vitamin E is an inclusive term for all tocopherols (alpha, beta, gamma, sigma) and 
tocotrienols  (alpha, beta, gamma, sigma) with alpha-tocopherol as the tocopherol of 
greatest bioactivity (Brigelius-Flohe et. al. 1999).  These tocopherols consist of a 
chromanol ring, with a hydroxyl group capable of donating a hydrogen atom to reduce 
free radicals and a hydrophobic side chain allowing for penetration into biological 
membranes.  Alpha-tocopherol (Figure 1) may enter circulation via the lymphatic system 
after absorption into the intestine. In the cell, alpha-tocopherol functions by scavenging 
and destroying ROS, inhibiting propagation of free radical reactions as a chain breaking 
antioxidant (Brigelius-Flohe et. al. 1999, Karaday, A et. al. 2009), thus preventing chronic 
diseases associated with oxidative stress (Brigelius-Flohe et. al. 1999).  Benchtable 
research linked alpha-tocopherol’s limited ability to protect neurons to its lipophilic 
nature, retarding its ability to quench cytosolic ROS, most importantly those generated 
from antecedent membrane oxidative damage.  Similarly, free alpha-tocopherol has only 
demonstrated limited efficacy in clinical trials, an inability attributed to limited access to 
secondary ROS that have radiated into the cytosol (Shea, T et.al. 2005).  Entrapment of 
alpha-tocopherol within polymeric nanoparticles should decrease these limitations by 
strategically placing the antioxidant in necessary locations such as the cytosol.   
 
 
 
 
 
 
 
 
Figure 1: Chemical structure of alpha tocoperol 
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1.1.2 Lutein: Function and Delivery  
 Lutein (Figure 2) found in many vegetables (e.g. sweet potato, leafy greens) and 
egg yolk is an oxygenated carotenoid, belonging to the xanthopyll family (Mitri, K et. al. 
2011, Boon, C et.al. 2010).    Existing as a known lipophilic carotenoid naturally found in 
the body, it is more concentrated in the macula lutea of the human eye, and recognized 
for improving and protecting vision (Mitri, K et. al. 2011).  Also, lutein may be found in the 
skin and linked with protection from UV exposure and skin cancer.  Lutein is considered 
to protect the body by a number of antioxidant mechanisms including free-radical 
scavenging or quenching of singlet oxygen that may damage deoxyribonucleic acid 
(DNA) (Mitri, K et. al. 2011, Boon, C et.al. 2010).  Similar to alpha-tocopherol, lutein 
cannot reach its full potential due to its poor bioavailability (Idit, A et.al. 2003, Reboul, E 
et. al. 2006).  Lutein’s characteristic hydrophobicity, isomerizable multi-conjugated 
double bonds structure leads to fast oxidation and degradation, and type of matrix in 
which incorporated are factors that most affect lutein bioavailability (Idit, A et.al. 2003, 
Mitri, K et. al. 2011).  A method that would protect lutein from oxidation on route to the 
cell in a form of polymeric nanoparticles is desirable to fully take advantage of its 
antioxidant potential.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Chemical structure of lutein contains polyene chain of nine 
conjugated double bonds in the polyene chain in the presence of two 
hydroxyl groups 
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1.2 Nanoparticle Elements  
 
1.2.1 Nanoparticle Entrapment  
 
 Nanoentrapment involves the formation of actively loaded particles of controlled 
properties measuring from 1 to 1000 nm in diameter (Fang, Z et. al. 2010).  The 
bioactives may be adsorbed on the sphere surface or entrapped within the particle.  The 
accepted consensus is that nanoparticles as compared to micron-sized particles provide 
greater surface area; nanoparticles can protect the bioactive from degradation, improve 
the dispersibility of the entrapped bioactive, and offer better precision in targeting the 
entrapped material (Fang, Z et.al. 2010). Several technologies of entrapment have been 
developed, including spray drying, emulsification, coacervation, liposome entrapment, 
and entrapment in polymeric nanoparticles (Fang, Z et.al. 2010).  A very common 
method used to form polymeric nanoparticles is emulsion evaporation method facilitated 
by microfluidization seen in Figure 3. 
 
 
Figure 3: Visual summary of nanoparticle synthesis  
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 An aqueous phase is formed by dissolving surfactant in solvent saturated 
nanopure water while mixing. An organic phase is formed by dissolving the polymer into 
solvent  (and hydrophobic bioactive if applicable).  The organic phase is pipetted into 
aqueous phase under stirring at 300 RPM.  The final emulsion is passed 3 times 
through a microfluidizier (Microfluidics M-110P) at 30 K (KPSI) process pressure.  
Following evaporation of the organic solvent, the nanoparticle suspension is freeze-
dried to form the nanoparticle powder.  
 Limitations may exist in delivering antioxidants by polymeric nanoparticles. While 
nanoparticles are found advantageous in increasing circulation and benefit from ease of 
synthesis with well researched biodegradable polymers, the application of these 
systems may be limited by general toxicological concerns (Sundar, S et. al. 2010). 
Poly(lactic-co-glycolic acid (PLGA) is known to hydrolyze and degrade enzymatically in 
the body. The resulting lactic acid and glycolic acids are readily metabolized and 
removed from the body by the citric acid cycle.  Furthermore the product formation is at 
a rate that will not affect cell function (Semete, B et.al. 2010).  Still, reported PLGA 
particles smaller than aerodynamic diameter <100 nm have a greater inclination to 
cause pulmonary toxicity due to deeper penetration allowable due as their small size, 
larger surface area, than larger same characteristic particles (Nel, A et.al. 2006, 
Semete, B  et. al. 2010).  Furthermore, there are reports of NPs being facilitated across 
biological barriers such as the blood-brain barrier (BBB), the skin, and the tight junctions 
of various epithelial layers (Semete, B. et.al. 2010, Johnston, H.J. et. al. 2010).  NPs 
may distribute to sites distal to points of entry resulting in toxicity being expressed at 
other unintentional targets in the body (Oberdorster et al. 2005, Johnston, H.J. et. al. 
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2010).  It is for these considerations that more studies are deemed necessary to 
understand cellular NP uptake, biotoxicity, and trafficking of PLGA nanoparticles loaded 
with antioxidants. More extensive human (i.e. inhalation, dermal penetration) and 
environmental nanoparticle exposure studies  (Maynard et al., 2007,Oberdorster et al. 
2005, Johnston, H.J. et. al. 2010) must be done to understand the biotoxicity effects of 
polymeric nanoparticles even for particles made of biodegradable polymers such as 
PLGA. 
1.2.2 PLGA  
 Particle size, surface charge and hydrophobicity play a vital role in the ability of 
nanoparticles to be translocated through the cell.  Polymer selection plays an important 
role in the nanoparticle functionality and bioreactivity. Poly (D,L-Lactide-co-glycolide), 
structure as seen in Figure 4, is an example of a common synthetic polymer used in 
biological applications that is approved by the FDA as GRAS for pharmaceutical 
applications (Jain, RA 2010, Jalil and Nixon 1990). Its degradation is thought to occur 
mostly through hydrolysis, where it breaks down into its monomers, lactic acid and 
glycolic acids. The monomers, lactic acid and glycolic acids, are metabolized through 
the Kreb’s cycle and eliminated as harmless waste products, carbon dioxide and water 
(Brady, J et.al. 1973, Tice and Cowsar 1984).   
 
 
 
 
 
 
Figure 4: Chemical structure of Poly (lactic-co-glycolic) acid 
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1.2.3 Chitosan  
 Chitosan, structure seen in Figure 5, is a N-deacetylated derivative of chitin and 
a naturally occurring biopolymer with minimal toxicity compared to other cationic 
polymers such as poly-L-lysine and polyethyleneimine (Nafee, N et.al. 2009). Due its 
positive charge and mucoadhesive properties, chitosan was identified as a potential 
component to increase GI transit time of nanoparticles and consequently bioavailability 
of entrapped active components. Even though chitosan has not yet been approved by 
the Food and Drug administration as GRAS for food applications, it is believed to be 
appropriate for bioactive delivery in biological systems, due to its high bioabsorbability 
(Kumar, R 2000, Hou, W.M. et.al. 1985, Miyazaki, S. et.al. 1981).  
 
 
 
 
 
 
 
 
 
 
 Chitosan-coated PLGA particles (PLGA/Chi) were developed to utilize the 
mucoadhesive property of chitosan and PLGA’s ability to efficiently entrap hydrophobic 
and hydrophilic drugs (Kawashima, Y. et.al. 2000). Various formulations of PLGA and 
PLGA/Chi particles have been applied to promote sustained drug release, for drug 
targeting, or to increase drug absorption (Murugeshu, A. 2010).   
1.3 Objectives  
 Some progress has been made to support the concept of improving 
antioxidant and biological activity of various nanodelievered antioxidants. 
However a more detailed study of the particle stability and chemical stability of 
Figure 5: Chemical structure of chitosan 
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entrapped components when exposed to different medias of varying complexity is 
needed to build confidence in results of in-vitro and in-vivo studies linking 
antioxidant activity to nanodelivery systems.  
 The objectives of the study were: (i) To optimize the process of making 
poly(lactic-co-glycolic) acid (PLGA) nanoparticles of controlled properties with 
entrapped antioxidant  components, alpha-tocopherol and lutein (ii) To assess 
physical stability of the nanoparticles when exposed to various biological medias 
(iii) To assess the chemical stability of entrapped antioxidants when exposed to 
various media over a time span relevant for in-vitro and in-vivo applications 
testing functionality of the entrapped antioxidant or toxicity of the delivery system 
loaded with the bioactive.  
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CHAPTER 2.  PHYSICAL STABILITY OF POLY (LACTIC-CO- 
   GLYCOLIC ACID) AND PLGA/CHITOSAN  
   NANOPARTICLES AND CHEMICAL STABILITY OF  
   ENTRAPPED ALPHA- TOCOPHEROL AND LUTEIN 
 
 Nanoparticles, of lipidic and polymeric nature, as a means of antioxidant 
entrapment have shown vast potential in cancer prevention, detection and augmenting 
of existing treatments (Hoe Do, J et.al. 2008, Smith, A et. al. 2010, Shea, T et. al. 2005). 
The effectiveness of the nanoentrapped bioactive depends on preserving the stability, 
bioactivity and bioavailability of the active ingredients.  Siddiqui, I et.al. for example 
synthesized PLA-PEG EGCG loaded nanoparticles and proved that entrapped EGCG 
degraded slower compared to free EGCG which provided for improved stability and 
better bioavailability of EGCG (Siddiqui, I et. al. 2009). Nanoentrappment of polyphenols 
when compared to the free antioxidants, can efficiently improve their effectiveness as 
shown by several studies (Yallapu, M et. al. 2010, Fang, Z et. al. 2010, Siddiqui, I et. al. 
2009).  
 While many studies exist to support the use of antioxidant entrapped 
nanoparticles to determine efficacy of the delivery systems, there is a specific need to 
understand physical stability and chemical stability of these particles within selected 
biological mediums(Yallapu, M et. al. 2010, Fang, Z et. al. 2010, Siddiqui, I et. al. 2009).  
As nanoparticle studies have progressed to the use of cells and animal studies(Gonnet, 
M et.al. 2010, Ronzani, C. et.al. 2014, Rescignano, N. et.al. 2013, Jayeeta, D. 
et.al.2010), few papers report on possible transformation of the nanoparticle under 
conditions of testing throughout the studies(Rodriguez-Emmeneggera, C. et.al. 2011, 
Ocal, H. et.al.  2014, Zubris, K.A.V. et. al. 2013) or are limited in scope (Ranganathan, A 
et.al.  2013).   
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 The goal of the study was to assess physical stability of nanoparticles when 
suspended in water, PBS, HBSS, cell culture media and chemical stability of entrapped 
alpha-tocopherol or lutein under the same conditions.   
2.1 Materials 
 Poly(lactide-co-glycolide acid) (PLGA) 50:50, molecular weight 40,000-75,000 
g/mol, ascorbic acid, D,L- alpha tocopherol (97 %), sodium taurocholate, D (+) − 
trehalose dihydrate, sodium acetate, and sodium chloride, polyvinyl alcohol (PVA) 87-
89% hydrolyzed (31,000-50,000 g/mol), Tween 80, alpha-tocopherol, ethanol, Hanks’ 
Balanced Salt Solution (HBSS), acetic acid, and Phosphate Buffered Solution (PBS) 
were purchased from Sigma-Aldrich (St. Louis, MO). Acetone, ethanol, acetonitrile, 
ethyl acetate were HPLC grade (Mallinckrodt Baker, Pittsburgh, NJ).   Methanol, 
anhydrous sodium acetate, and isopropanol were obtained from EMD Chemicals Inc. 
(Gibbstown, NJ, USA). Nanopure water was obtained using Nanopure Diamond 
(Barnstead international, Dubuque, IA, USA). Williams’ Medium E (WME) was 
purchased from Invitrogen.  Chitosan with an average molecular weight of 150 − 400 
kDa and 70 – 90 % degree of deacetylation was obtained from NovaMatrix Ultrapure 
Polymer Systems Inc. (Sandvika, Norway). 100 kDa Cellulose Ester biotech membrane 
tubing and closures were obtained from Spectrum Laboratories Inc. (Rancho 
Dominguez, CA, USA). 
2.2 Methods  
 
2.2.1 Synthesis of PLGA, PLGA/Chitosan Particles with Entrapped Bioactives 
 
 Emulsion evaporation was used for particle synthesis as it supplies a large 
quantity of particles with high entrapment efficiency (Zigoneanu, I et. al. 2008).  The 
bioactives (aT and L) were each entrapped in PLGA nanoparticles by a method 
11 
 
similar to emulsion evaporation method as described in a previous paper by 
Zigoneanu, I et. al.  (Zigoneanu, I et. al 2008).  The use of microfluidization previously 
illustrated in Figure 3 allowed for larger quantities of particles to be synthesized.  For 
the organic phase, 200 mg of PLGA was dissolved in 8 ml ethyl acetate with 20 mg of 
the selected bioactive.  The aqueous phase consisted of 0.3% w/v PVA or 2% w/v 
PVA in nanopure water saturated with 4 ml ethyl acetate for NP(aT) and NP(L) 
respectively.  The organic phase was pipetted into 40ml aqueous phase under stirring 
at 300 rpm.  The emulsion (o/w) was passed 3 times through a microfluidizier 
(Microfluidics M-110P) at 30 K (KPSI) process pressure. Solvent was evaporated under 
vacuum (40 mm Hg) and nitrogen flow (100 ml min−1) for 10 min by rotovap (Buchi 
R-124, Buchi Analytical Inc., New Castle, DE, USA). After evaporation, the color of 
the suspension changed from milky to a clear transparent color, which is 
characteristic of small polymeric nanoparticles in suspension.   
 Free PVA and bioactive were removed through dialysis by a Spectra/POR CE 
membrane  MWCO: 100,000 (Spectrum Laboratories, Rancho Dominguez, CA) in 
nanopure water over 48-72 hours.  The nanoparticle suspension was placed in the 
membrane and suspended in 1.5 L nanopure water for an  in i t i a l  24 hours. The 
water was changed incrementally. For PLGA/Chi nanoparticles, the PLGA NP 
suspension was combined with a chitosan solution.  After particle dialysis half of the 
ten mg of chitosan was dissolved solution at 1mg/ml than added under magnetic 
stirring to half of the dialyzed NP suspension.  Resulting particles PLGA and 
PLGA/Chi particles in suspension were then combined with trehalose at 1:1 of 
particle components and put to liophilizer FreeZone 2.5 Plus  (Labconco, Kansas City, 
MO, USA) at −80 °C.    Freeze dried particles were stored at 4°C prior to further use.    
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2.2.2 Synthesis of Bioactive Emulsion as Control 
 Oil-in-water emulsions were prepared for lutein and alpha tocopherol to be used 
as controls. The method employed dropwise addition of 10wt% lipid phase in to 90 wt% 
aqueous phase under homogenization. The aqueous phase consisted of 1 wt% Tween 
80 and buffer solution (10 mM sodium phosphate buffer, pH 7.0). The lipid phase was 
made of oleic acid and AO (L or aT) at a final concentration based on NP entrapped 
AO. The initial emulsion was sonnicated  (VC505, Sonics & Materials Inc., Newtown, 
CT, USA) at 31% amplitude for 1 min, 2 sec pulse to form nanoemulsions. 
2.2.3 Particle Size and Zeta Potential Measurement 
 Dynamic light scattering was used to determine diameter mean size, size 
distribution, and polydispersity index (PDI) of 1:10 particle dilution of particle samples 
with a Zetasizer (Malvern Instruments, Malvern, UK).  The mean values of size and PDI 
was determined using a mono- modal distribution.Charge for the diluted samples will 
be determined by directly correlated zeta potential measurements using the Zetasizer 
preset for the established Helmholtz-Smoluchowski’s equation.  The values were 
determined for re-suspended dried particles in triplicates.      
2.2.4 Entrapment Efficiency Measurement 
2.2.4.1 Entrapment efficiency of alpha-tocopherol measurement by HPLC  
 The entrapment efficiency was assessed by a method altered from a previous 
paper (Yallapu, M et. al. 2010) Synthesized particles were centrifuged for 30 
minutes at 30,000 RPM.  The pellet was washed once with Nanopure water and 
resuspended to remove excess PVA, PLGA, and free bioactives.  Extraction of 
bioactive was achieved by the dissolution of lyophilized NP 1mg/ml in 95:5 
acetonitrile:water.  Samples were vortexed under slow speeds with Fisher Scientific 
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digital vortex mixer at 15 minutes.  Samples were left for 1hr at room temperature in 
solution for total leaching of bioactive into acetonitrile.  Supernatant was collected 
after centrifugation with an Allegra 64R centrifuge (Beckman Coulter, Fullerton, CA, 
USA), at 30,000 RPM for 60 min.  The supernatant was injected in the HPLC for 
quantification of the entrapped aT.  Bioactive concentrations were determined by 25 
ul HPLC injections in methanol mobile phase at a flow rate of 1.0 ml/min, compared 
to a developed standard curve.  The entrapment efficiency was calculated as 
follows: 
EE=(aTE/aTT)×100% 
Equation 1: Where aTE = amount of aT found entrapped in known concentration of 
particles relative to standard curve; aTT = theoretical amount entrapped in known 
concentration of particle.  
 A standard curve Appendix D, with a linear dynamic range of 0 – 10 ug/ mL for 
αT in 95:5 acetonitrile to H2O, was generated and used to convert the area under curve 
(auu) to αT concentration.  
2.2.4.2 Entrapment efficiency lutein measurement by spectrophotometry 
 
 Entrapment efficiency of lutein was calculated similarly to that for alpha-
tocopherol, with the exception that a spectrophotometer was used.  Samples were left 
for 2 hours at room temperature in solution for total leaching of bioactive into 
acetonitrile.  Bioactive concentrations were determined using a Geminys 6 
spectrophotometer (Thermo Scientific, Waltham, MA) at wavelength 445 nm, compared 
to a developed standard curve.  The entrapment efficiency was also calculated as 
follows: 
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EE=(LE ⁄ LT )×100% 
Equation 2: Where LE = amount of L found entrapped in known concentration of 
particles relative to standard curve; LT = theoretical amount entrapped in known 
concentration of particle.   
 A standard curve Appendix D, with a linear dynamic range of 0 – 60 ug/ mL for 
lutein in 95:5 acetonitrile to H2O, was generated and used to convert the absorbance 
(abs) to lutein concentration. 
2.2.5 Assessment of Nanoparticle Physical Stability  
 The physical stability of loaded nanoparticles was studied over a pH range of 1.5 
to 10 progressing from acidic to basic pH  and  a separate study of basic to acidic pH.  
Particles were suspended at a concentration of 0.1mg/ml in pH-adjusted nanopure 
water  using 1M NaOH and 1 M HCL (basic or acidic pH) and pH titrations were carried 
out, while measuring size, PDI and zeta potential using the Malvern Zetasizer Nano 
ZS/MPT-2 (Malvern Instruments Inc., MA, USA).  Diluted solutions of HCL Acidic solns: 
0.1, 0.25, 0.5 M and NaOH Basic solns: 0.1, 0.25, 0.5 M were titrants used for pH 
adjustments.   
 For the measurement of size and PDI values, stock amount of NP(AO)/ml were 
placed in to suspension in each medium (water, pbs, hbss, cell media) at room 
temperature.  An aliquot of each suspension was taken at pre-established time points, 
diluted then measured for size and PDI by Malvern Zetasizer Nano ZS/MPT-2 (Malvern 
Instruments Inc., MA, USA).  The process was triplicated.    
2.2.6 Chemical Stability of Entrapped Alpha-tochopherol  
 The study of chemical stability of entrapped aT in nanoparticles was done as 
follows.  Prepared nanoparticles were suspended in each medium (water, pbs, hbss, 
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cell media) to form a stock amount of NP(aT)/ml and emulsion(aT) at room temperature.  
An aliquot was taken at pre-established time points over 24 hrs.  Samples were placed 
into a volume of ACN at a final ratio of 95:5 ACN:media and mixed thoroughly to disrupt 
the NPs.  The AO was extracted for 1 hr.  Samples were then centrifuged at 30,000 rpm 
for 1 hr.  The supernatant was filtered and free alpha-tocopherol was determined by 
HPLC 25 ul injection, 1.0 ml/min, methanol mobile phase, FLD1 A, Ex=290, Em=330, 
DAD1 A, Sig=295,4 Ref=360,100 and calculated by appropriate calibration curve of the 
free aT. Each study was performed in triplicate.  
2.2.7 Chemical Stability of Entrapped Lutein  
 The stability of entrapped lutein was also studied in vitro.  Prepared nanoparticles 
were suspended in each medium (water, pbs, hbss, cell media) to form a stock amount 
of NP(L)/ml and emulsion(L) at room temperature.  An aliquot was taken at pre-
established time points over 72 hrs.  Samples were placed into a volume of ACN at a 
final ratio of 95:5 ACN:media and mixed thoroughly to disrupt the NPs.  The AO was 
extracted.  Samples were then centrifuged at 30,000 rpm for 1 hr.  Free lutein was 
determined by measuring the absorbance using UV/Vis spectrophotometer at 445 and 
calculated by appropriate calibration curve of its free antioxidants. Each study was 
performed in triplicate. 
2.2.8 Statistical Analysis 
 Two factor analysis of variance (ANOVA) was used to determine if any significant 
difference in particle size, or chemical stability existed with respect to media and time 
for PLGA and PLGA/Chi particles.   P-values less than or equal to 0.05 were considered 
significant.  Data set with strong correlations were individually evaluated by one way 
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ANOVA to identify if initial correlation is representative of a specific subset.  P-values of 
less than or equal to 0.05 were considered strongly significant and p-value less than 
0.1were deemed to have some significance.  Data is representative of triplicate 
measurements.  Statistical analyses were run in SAS® (SAS Institute Inc., Cary, NC, 
USA).   
2.3 Results and Discussion 
 
2.3.1 Stability of Particles over pH Titration 
 
 Preliminary titration studies were carried out on PLGA(L) to evaluate potential 
effect of pH on PLGA NP that should not be attributed to media type.  The resulting 
information can be found in Appendix A.  For particles placed initially in an acidic 
solution (Figure A-1) and brought to a basic pH the size saw a slight increase 
approximately 115 -140 nm as zeta potential decreased from a positive to negative 
value.  An isoelectric point was determined at pH 6.12. Particles initially suspended in a 
basic solution (Figure A-2) had a larger particle size increase.  Particles starting at 
approximately 115 nm increased to 275 nm as pH decreased.  Highly negative zeta 
potential approached 0 mV as pH dropped.  Particles appeared sensitive to large pH 
fluctuations similar to those encountered during GI transition if antioxidant loaded 
nanoparticles were administered orally.    
2.3.2 Physical Stability of PLGA and PLGA/Chitosan Particles in Media  
 Particles were re-suspended in various biological media including water, PBS, 
HBSS and cell growth media.  Periodically an aliquot was pulled and measured for 
physical stability properties by DLS.  The initial pHs of the suspension medias with no 
particles were measured for potential effect on particle properties.  These values were 
as follows: water pH=5, PBS pH=7, HBSS pH=7.5, media pH=8.  Final pH values 
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following the addition of the particles for PLGA NPs were: water pH=5.67, PBS 
pH=7.25, HBSS pH=7.67, media pH=8.17, and for PLGA/Chi NPs: water pH=5.09, PBS 
pH=6.92, HBSS pH=7.67 and media pH=7.25.  The emulsion had a pH of 5.5.  These 
values did not vary widely over the span of study and can be found in Appendix H.   
2.3.2.1 Physical stability of PLGA and PLGA/Chi NPs with entrapped alpha-tocopherol  
 The effect of solvent medium on physical particle stability over time was studied 
for PLGA(aT) and PLGA/Chi(aT).  Stability encompassed both size (see a, b, c, d, in 
Figure 6) and polydispersity (PDI) (see a, b, c, d in Figure 7).  Particles re-suspended in 
water, PBS, HBSS and media (WME) were observed for size (Z-ave, nm) and PDI (a.u.) 
at times 0, 4, 8, 12, 24 and 60 hours. PLGA/Chi particles as demonstrated in previous 
studies (Nafee, N et al 2009, Murugeshu,A 2010) produced an initial increase in 
average size when compared to PLGA particles due to high molecular weight of 
chitosan added on the surface of the PLGA Nps.  Initial size increases due to chitosan 
addition was from 88 to 177 nm in water, 92 to 126 nm in PBS, 91 to 313 nm in HBSS 
and 89 to 191 nm in media for PLGA(aT) and PLGA/Chi(aT) respectively.  While PLGA 
were different in size from PLGA/Chi NPs, it appeared that no significant change was 
achieved over time for both PLGA and PLGA/Chi particles when suspended in water, 
PBS, HBSS, and media for 60 hours (see a, c, e, g in Figure 6).  Likewise particles 
appear unaffected by medium in which re-suspended when comparing PLGA NP in 
various mediums.  PLGA/Chi NPs trended similarly, though PLGA/Chi particles values 
appeared smaller at all times, it was determined to not be significant with values of p > 
0.1.    
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 On the other hand PDI values (see a, b, c, d in Figure 7) were approximately 0.2-
0.3 a.u. for PLGA NP signifying uniform particle size while PDI of PLGA/Chi particles 
were higher, 0.4-0.6 a.u. which suggested a more non-uniform size distribution of these 
particles.  It was deemed that uniformity of particle sizes were a result of polymer type 
rather than any media affect.   
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Figure 6: Effect of media and polymer on NP(aT) physical properties measured by DLS 
for size in a) water, b) PBS, c) HBSS, d) WME media 
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2.3.2.2 Physical stability of PLGA and PLGA/Chi NPs with entrapped lutein   
 Similar to NP(aT), following NP synthesis a portion of the NP(L) was suspended 
in the selected medias (water, PBS, HBSS, and media) and changes tracked over  a 
time span of 24 hr due to know instability of lutein, time deemed sufficient for completion 
of  daily bench, cell and or animal studies. PLGA/Chi(L)  particles also  produced 
significantly larger initial average size when compared to PLGA particles (see a, b, c, d 
in Figure 8).   
 
Figure 7: Effect of media and polymer on NP(aT) physical properties measured by DLS 
for PDI in a) water, b) PBS, c) HBSS, d) WME media 
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Initial size increases were from 82 to 422 nm in water, 95 to 315 nm in PBS, 104 to 210 
nm in HBSS and 86 to 200 nm in media by addition of chitosan to PLGA(L) to form 
PLGA/Chi(L).  There also appeared to be no significant change in size over time for 
PLGA and PLGA/Chi particles when suspended in water, PBS, HBSS, and media (see 
a, b, c, d in Figure 8).  Likewise particles appeared unaffected by medium in which re-
suspended when comparing size of PLGA and PLGA/Chi NP in various mediums.  PDI 
values (see a, b, c, d in Figure 9) were approximately 0.15-0.3 for PLGA NP signifying 
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Figure 8: Effect of media and polymer on NP(L) physical properties measured by DLS 
for size in a) water, b) PBS, c) HBSS, d) WME media 
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uniform particle size while PLGA/Chi particles were between 0.3-0.6 which suggested 
possible aggregation or lack of uniformity in PLGA/Chi NPs.  Again the uniformity of the 
particles was generally associated with polymer selection rather than media.  The 
physical stability of particles appeared sufficient; however chemical stability was 
required before final conclusions could be made.  
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Figure 9: Effect of media and polymer on NP(L) physical properties measured by DLS 
for PDI in a) water, b) PBS, c) HBSS, d) WME media, f) PDI in WME media 
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2.3.3 Chemical Stability of Entrapped Bioactives in Media 
2.3.3.1   Alpha-tocopherol  
 Information on NP stability was needed in part to determine if suspension media 
affected NP(AO) in such a way as to potentially alter bench, cell or animal studies.  
Based on the amount of remaining alpha tocopherol in PLGA nanoparticles 
suspended in water, PBS, HBSS, and cell media (WME) and PLGA/Chi particles 
in water, PBS, HBSS, and cell media (WME) over time, as seen in a, b, c, d, and  
e, f, g, h  in Figure 10 respectively, it appears that nanoparticles confer a 
stability for the entrapped alpha-tocopherol in the various media similar to the 
emulsified alpha tocopherol seen in Figure 11.  From the presented figures the 
remaining entrapped alpha -tocopherol exhibited very little change in trended 
data with graphs appearing nearly identical.   
 However, when considering percent differences (not shown) from time 0 
hr, the alpha-tocopherol present in the emulsion declined over a 24 hr period as 
follows: by 3.64% at 4hr, 4.03% at 8 hr, 18.95% at 12 hr and 24.22% at 24 hr. 
Alpha tocohperol entrapped in PLGA NPs decreased by only 5.68% after 12 hrs, 
while that entrapped in PLGA/Chi(aT) decreased by 18.37% over 12 hr.  The 
higher percent difference for PLGA/Chi(aT) could be related to more aT released 
in solution thus being exposed to degradation in media as the chitosan 
component of the particle matrix degraded.  Still aT entrapped in emulsion and 
NPs remained relatively stable in all medias tested with PLGA(aT) faring better 
than other delivery systems (PLGA/Chi and emulsion).    
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Figure 10: Amount of remaining alpha tocopherol in PLGA nanoparticles suspended in 
(a) water, (b) PBS, (c) HBSS, and (d) WME media  and PLGA/Chi particles (e) water, (f) 
PBS, (g) HBSS, and (h) WME media  and PLGA/Chi over time 
24 
 
0
0.5
1
1.5
2
2.5
0 5 10 15 20 25 30
u
g/
m
l  
Time (hr) 
Emulsion(aT) 
 
 
2.3.3.2   Lutein  
 The amount of remaining lutein in PLGA nanoparticles suspended in 
water, PBS, HBSS, and cell media (WME) and PLGA/Chi particles in water, 
PBS, HBSS, and cell media (WME) over time as seen in a, b, c, d and e, f, g, h 
in Figure 13 respectively, indicated that lutein had a good stability when 
entrapped in PLGA NPs for 60 hr.  PLGA/Chi entrapped lutein remained 
unaffected in water, PBS and HBSS within 60 hr.  Lutein entrapped in PLGA/Chi 
In the presence of PBS began exhibiting a decline at 40 hr.  Both systems saw a 
significant decrease in stability at 72 hours when suspended in media.  Unlike 
the entrapped alpha tocopherol, emulsified lutein seen in Figure 12 degraded 
starting at 24 hr with signif icant degradation at 72 hr.  There appeared an initial 
strong significance p < .05 for analysis of variables.  Upon further inspection, or 
single ANOVA of particle in media over time, it was determined that only the 
change in lutein emulsion stability over time was significant.     
Figure 11: Amount of remaining alpha tocopherol in emulsion 
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 When percent differences were calculated from time 0 hr, the lutein 
present in the emulsion consistently declined over a 72 hr period as follows: at 4 
hr  25.26%, 8 hr 25.26%, 24 hr  41.40%, 48 hr 131.00%, and 72 hr 162.70.   
PLGA (L) in water performed better at earlier times and had a lower degradation 
over the 72 hr period (4 hr 4.14%, 8hr 8.46%, 24 hr 0.51%, 45 hr 6.28%, 72hr 
29.04%).  Increased degradation was expected due to the nature of lutein 
stability.  Still, the graphs made obvious the increased “protection” provided by 
entrapping the lutein when compared to the emulsion.  Also, higher percent 
difference for PLGA/Chi(L) could be attributed to more lutein released in solution 
thus being exposed to degradation in media as the chitosan component of the 
particle matrix potentially degraded.    
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12: Amount of remaining lutein in emulsion 
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Figure 13: Amount of remaining lutein in PLGA nanoparticles suspended in (a) water, 
(b) PBS, (c) HBSS, and (d) WME media and PLGA/Chi particles (e) water, (f) PBS, (g) 
HBSS, and (h) WME media  and PLGA/Chi over time 
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CHAPTER 3. CONCLUSIONS AND FUTURE WORK 
3.1 Conclusions  
 As a precursor to the invaluable studies being undertaken to evaluate the many 
uses of NP(AO), this research sought to demonstrate the effects (if any) of selected 
suspension media on NP physical stability and the entrapped AO chemical stability.  
Also, there was the potential to present duration times for nanoparticle stability in 
popular biological mediums.    
 PLGA/Chitosan(aT) nanoparticles synthesized by emulsion evaporation exhibited 
initial sizes (126-313 nm) approximately twice the size of PLGA NP (87-92 nm) when 
suspended in mediums.  PLGA/Chi(L) (82-104 nm) and PLGA(L) (200-422 nm) were 
similar in size disparity with particle sizes twice or three times as large.  Over the 
aforementioned time ranges, the sizes of the particles exposed to the different mediums 
(water, pbs, hbss and cell media) did not exhibit significant difference from the initial 
sizes, suggesting physical stability of particles.  Larger PDI values for PLGA/Chi(AO) 
particles indicated a higher polydispersity of the PLGA/Chi NPs.  Chemical stability of 
entrapped aT remained consistent in all media.  There appeared to be no media 
dependent degradation of alpha-tocopherol.  It was observed that alpha-tocoperol within 
the emulsion declined minimally.  A simple calculation of percent difference using the 
raw data supplied in Appendix F and G, showed alpha-tocopherol within emulsion had a 
percent difference of 24.22% by 24 hr.  PLGA(aT) and PLGA/Chi(aT) had 
improved values of 5.68% and 18.37% at 12 hr respectively.  The difference was 
more obvious for those systems involving lutein.  As previously discussed, from 
the initial “suspension” the percent difference of lutein remaining in the emulsion 
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increased over the 72 hr period for value as high as 162.70% while the PLGA (L) 
in water exhibited 29.04% over a 72 hr period.  This demonstrated that the 
similarity of the measurements decreased over time.  Initial medium pH values in 
water at 5, PBS at 7, HBSS at 7.5, Media at 8, and final values in a similar range 
allowed any notable trends to be attributed to media selection. 
 From the results any particle suspension should preferably be used within the 
first 24 hr.  The idea of simple vs more complex media did not appear to significantly 
affect particle properties.  This study confirms the physical and chemical stability of 
NP(aT) and NP(L) within various medium over a time deemed sufficient for bench and 
biological studies.  It allows for a fair comparison of PLGA and PLGA/Chi particles with 
entrapped lutein or aT with equal initial EE.  Also, the chemical stability data was 
consistent with the now generally accepted assertion that the NP protected or extended 
the bioactive stability when compared to the “free” bioactive emulsion.   Rather the 
“free” bioactive may prove to be the limiting factor as was the case for unstable lutein.  
Still, when not a study requirement, PBS would not be recommended for systems 
involving chitosan modified particles.  Thus, for studies analyses, consider the time 
frame of studies when incorporating emulsions as a control to a nanoparticle treatment.   
Future work and considerations should be given before undertaking any major studies.     
3.2 Future Work 
 To determine the full extent of the effect of the media on NP(AO), varying 
concentrations of NP solution in the medias should be compared to these studies.  
Provided more time, release studies should be carried out in a similar manner along 
with additional repetitions to calculate degradation kinetics.  To expand upon this study 
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additional bench, cell and animal studies should be completed to evaluate the effect of 
the suspension medium over time on bioavailability of the entrapped bioactives.  Also, 
consideration should be given to the type of entrapped bioactive (i.e. hydrophilic, 
hydrophobic), temperature of suspension and other potential factors of a study 
methodology that may impact the NPs.   
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APPENDIX A pH Titration Measurements Obtained by Dynamic 
Light Scattering 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A-1: Acidic to basic  titration measurements for PLGA(L) size and zeta potential  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A-2: Basic  to acidic  titration  measurements for PLGA(L) size and zeta potential  
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APPENDIX B NP(aT) Property Measurements by Dynamic Light 
Scattering 
 
Table B-1   Raw data for the particle properties characterized using dynamic light 
scattering (Malvern Zetasizer Nanoseries) within various media from 0 to 60 hr.   
 
  Repetition 1 Repetition 2 Repetition 3 
Sample 
Time(
h) 
Z-Ave 
(d.nm) 
PDI 
(a.u.) 
Z-Ave 
(d.nm) 
PDI 
(a.u.) 
Z-Ave 
(d.nm) 
PDI 
(a.u.) 
PLGA(aT) in Water 0 108.13333 
0.03766
7 
80.92333
3 
0.258 
75.86333
3 
0.301 
PLGA(aT) in PBS 0 98.486667 
0.16666
7 
93.18333
3 
0.18233
3 
85.75666
7 
0.25066
7 
PLGA(aT) in HBSS 0 94.89 
0.21033
3 
87.69666
7 
0.21766
7 
92.44 
0.19966
7 
PLGA(aT) in Media 0 91.68 
0.21966
7 
82.77333
3 
0.24866
7 
92.22333
3 
0.24433
3 
Emulsion(aT) 0 354.66667 0.482 
397.7666
7 
0.46733
3 
371.2 
0.44366
7 
PLGA/Chi(aT) in 
Water 
0 227.8 
0.43066
7 
119.1 
0.55366
7 
185.1333
3 
0.318 
PLGA/Chi(aT) in 
PBS 
0 141.86667 
0.26266
7 
63.24 
0.74133
3 
173.5333
3 
0.28066
7 
PLGA/Chi(aT) in 
HBSS 
0 156.53333 
0.38566
7 
454.5 
0.46966
7 
330.5 0.561 
PLGA/Chi(aT) in 
Media 
0 141.2 
0.40133
3 
230.3 0.413 202.7 
0.48666
7 
PLGA(aT) in Water 4 96.986667 0.156   66.39 
0.45166
7 
PLGA(aT) in PBS 4 86.21 0.246 
542.9666
7 
0.57233
3 
83.58333
3 
0.25866
7 
PLGA(aT) in HBSS 4 89.686667 0.254 238.1 0.42 
89.22666
7 
0.23 
PLGA(aT) in Media 4 82.64 
0.27066
7 
155.3 0.245 87.32 0.239 
Emulsion(aT) 4 619.86667 
0.94133
3 
980.2 
0.88466
7 
528.7 
0.64466
7 
PLGA/Chi(aT) in 
Water 
4 210.06667 
0.42933
3 
415.5 0.699 
172.4666
7 
0.27066
7 
PLGA/Chi(aT) in 
PBS 
4 174.16667 0.133   
139.8333
3 
0.423 
PLGA/Chi(aT) in 
HBSS 
4 152.7 
0.44433
3 
955 
0.95866
7 
208.7 
0.46566
7 
PLGA/Chi(aT) in 
Media 
4 136.53333 
0.40066
7 
426.8333
3 
0.90433
3 
250.4 
0.55733
3 
PLGA(aT) in Water 8 94.37 
0.18733
3 
64.21666
7 
0.43866
7 
79.97 
0.29233
3 
PLGA(aT) in PBS 8 88.45 
0.23266
7 
79.73333
3 
0.276 93.28 0.223 
PLGA(aT) in HBSS 8 86.076667 
0.25533
3 
83.05666
7 
0.249 
84.14666
7 
0.26533
3 
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PLGA(aT) in Media 8 80.823333 
0.28033
3 
79.60333
3 
0.27333
3 
85.11666
7 
0.27133
3 
Emulsion(aT) 8 479.9 
0.68966
7 
424.5666
7 
0.693 
421.8666
7 
0.48766
7 
PLGA/Chi(aT) in 
Water 
8 231.76667 0.439 185.7 0.34 
191.6666
7 
0.35633
3 
PLGA/Chi(aT) in 
PBS 
8 80.54 0.531 119 
0.47266
7 
119.3666
7 
0.467 
PLGA/Chi(aT) in 
HBSS 
8 192.2 
0.54033
3 
165.6 
0.30566
7 
232.4333
3 
0.50366
7 
PLGA/Chi(aT) in 
Media 
8 148.7 
0.38633
3 
174.5666
7 
0.34133
3 
233.6 
0.70566
7 
PLGA(aT) in Water 12 101.52 0.129 73.81 
0.29933
3 
66.52333
3 
0.45566
7 
PLGA(aT) in PBS 12 95.096667 
0.18933
3 
78.90333
3 
0.28466
7 
79.97333
3 
0.28533
3 
PLGA(aT) in HBSS 12 98.25 0.192 103.8 
0.10566
7 
82.53666
7 
0.26433
3 
PLGA(aT) in Media 12 89.493333 
0.22733
3 
91.16 0.207 
86.56333
3 
0.25166
7 
Emulsion(aT) 12 391.36667 
0.50766
7 
606.0666
7 
0.546 357.6 0.485 
PLGA/Chi(aT) in 
Water 
12 235.53333 
0.43333
3 
196.7666
7 
0.38633
3 
184.4666
7 
0.32133
3 
PLGA/Chi(aT) in 
PBS 
12 121.2 0.428 194.7 
0.35466
7 
110.5 
0.47133
3 
PLGA/Chi(aT) in 
HBSS 
12 180.4 
0.39566
7 
149.1 
0.29966
7 
218.2333
3 
0.48766
7 
PLGA/Chi(aT) in 
Media 
12 155.63333 0.392 
166.7666
7 
0.38466
7 
285.8 
0.57466
7 
PLGA(aT) in Water 24 107.06667 
0.08666
7 
102.94 0.107 100.05 
0.16966
7 
PLGA(aT) in PBS 24 97.31 
0.18966
7 
107.7333
3 
0.161 
85.45666
7 
0.278 
PLGA(aT) in HBSS 24 96.53 
0.21666
7 
90.75 
0.22133
3 
89.14333
3 
0.26766
7 
PLGA(aT) in Media 24 88.036667 
0.24766
7 
88.89333
3 
0.235 
82.97333
3 
0.29 
Emulsion(aT) 24 709.26667 0.67 
361.9666
7 
0.48733
3 
385.3666
7 
0.62166
7 
PLGA/Chi(aT) in 
Water 
24 180.26667 
0.26433
3 
187.6666
7 
0.32366
7 
164.7666
7 
0.248 
PLGA/Chi(aT) in 
PBS 
24 131.6 0.402 
114.7666
7 
0.454 123.3 0.38 
PLGA/Chi(aT) in 
HBSS 
24 191 0.429 172.2 
0.37633
3 
223.8333
3 
0.519 
PLGA/Chi(aT) in 
Media 
24 159.36667 0.414 187.5 
0.46766
7 
222.5333
3 
0.86866
7 
PLGA(aT) in Water 60 93.553333 
0.20466
7 
102.02 
0.12266
7 
101.73 0.16 
PLGA(aT) in PBS 60 88.203333 0.264 
92.98333
3 
0.21966
7 
115.6666
7 
0.196 
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PLGA(aT) in HBSS 60 94.286667 0.232 
94.89666
7 
0.19633
3 
183.7666
7 
0.25733
3 
PLGA(aT) in Media 60 117.13333 0.181 
105.8666
7 
0.32033
3 
135.5333
3 
0.36933
3 
Emulsion(aT) 60 
  
    
PLGA/Chi(aT) in 
Water 
60 550.46667 0.321 
192.1333
3 
0.37666
7 
155.1 0.178 
PLGA/Chi(aT) in 
PBS 
60 130.4 0.257   124 
0.23766
7 
PLGA/Chi(aT) in 
HBSS 
60 209.5 0.333 
165.3666
7 
0.31266
7 
198.3666
7 
0.61333
3 
PLGA/Chi(aT) in 
Media 
60 175.43333 
0.44766
7 
184.8333
3 
0.411 257.6 
0.67266
7 
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APPENDIX C NP(L) Property measurements by Dynamic Light 
Scattering 
 
Table C-1   Raw data for the particle properties characterized using dynamic light 
scattering (Malvern Zetasizer Nanoseries) within various media from 0 to 24 hr. 
 
  Repetition 1 Repetition 2 Repetition 3 
Sample  Time(h) Z-Ave (d.nm) PDI (a.u.) 
Z-Ave 
(d.nm) 
PDI 
(a.u.) 
Z-Ave 
(d.nm) 
PDI 
(a.u.) 
PLGA(L) in Water 0 103.45 0.1155 55.355 0.5345 88.195 0.2435 
PLGA(L) in PBS 0 112.4 0.112 109.4 0.1 64.04 0.5495 
PLGA(L) in HBSS 0 111.85 0.0985 108.65 0.0805 91.01 0.2855 
PLGA(L) in Media 0 52.3 0.5665 111 0.153 93.33 0.271 
Emulsion(L) 0 328.25 0.436 266.4 0.4135   
PLGA/Chi(L) in Water 0 261.45 0.392 730.65 0.576 274.4 0.418 
PLGA/Chi(L) in PBS 0 232.35 0.3485 432.75 0.488 280.15 0.4325 
PLGA/Chi(L) in HBSS 0 127.65 0.4125   291.35 0.509 
PLGA/Chi(L) in Media  0 126.9 0.3605 371.9 0.4375 102.1 0.2485 
PLGA(L) in Water 4 99.905 0.116 103.6 0.1 43.305 0.6085 
PLGA(L) in PBS 4 110.95 0.116 110.85 0.092 110.15 0.173 
PLGA(L) in HBSS 4 110.6 0.094 107.2 0.0845 73.895 0.394 
PLGA(L) in Media 4 114.35 0.1045 161.9 0.3525 164.85 0.2625 
Emulsion(L) 4 172.1 0.4515 520.05 0.5795 266.2 0.4955 
PLGA/Chi(L) in Water 4 234.9 0.313 365.2 0.4585 266.95 0.395 
PLGA/Chi(L) in PBS 4 159.4 0.3 477.55 0.533 283 0.5525 
PLGA/Chi(L) in HBSS 4 135.2 0.409 219.05 0.492 102.65 0.292 
PLGA/Chi(L) in Media  4 73.58 0.3915 101.6 0.0925 98.325 0.176 
PLGA(L) in Water 8 115.3 0.0975 47.945 0.543 116.55 0.1135 
PLGA(L) in PBS 8 114.15 0.1145 52.74 0.546   
PLGA(L) in HBSS 8 117.4 0.1175 51.435 0.546 108.2 0.1735 
PLGA(L) in Media 8 244.6 0.365 944.75 0.78 266.15 0.4055 
Emulsion(L) 8 242.5 0.3385 385.45 0.472   
PLGA/Chi(L) in Water 8 158.2 0.349 244.4 0.431   
PLGA/Chi(L) in PBS 8 252.85 0.3535 166.5 0.4765 115.5 0.21 
PLGA/Chi(L) in HBSS 8 102.1 0.0835 102.85 0.0915 62.315 0.465 
PLGA/Chi(L) in Media  8 113.7 0.1005 41.595 0.6045 115.2 0.1135 
PLGA(L) in Water 12 112.8 0.106 54.72 0.5345 89.95 0.302 
PLGA(L) in PBS 12 120.25 0.1465 48.59 0.5415 323.89 0.439 
PLGA(L) in HBSS 12 288.35 0.394 645.6 0.6235   
PLGA(L) in Media 12   426.4 0.678 262.75 0.4145 
Emulsion(L) 12 152.15 0.415 0 0   
PLGA/Chi(L) in Water 12 136.9 0.4625 164.1 0.715 110.05 0.275 
39 
 
PLGA/Chi(L) in PBS 12 74.44 0.4135 88.605 0.2465 95.065 0.1805 
PLGA/Chi(L) in HBSS 12 115.05 0.125 87.125 0.2875 117.15 0.089 
Table Continued 
PLGA/Chi(L) in Media  12 117.85 0.144 110 0.0855 99.19 0.253 
PLGA(L) in Water 24 116.55 0.082 77.75 0.32 96.98 0.241 
PLGA(L) in PBS 24 370.95 0.442 780.3 0.528 297.65 0.4495 
PLGA(L) in HBSS 24 216.5 0.34 385 0.472 183.6 0.4645 
PLGA(L) in Media 24 156.1 0.415 169.4 0.428 305.25 0.474 
Emulsion(L) 24 129.45 0.3615 126.1 0.4665 113.35 0.195 
PLGA/Chi(L) in Water 24 103.45 0.1155 55.355 0.5345 88.195 0.2435 
PLGA/Chi(L) in PBS 24 112.4 0.112 109.4 0.1 64.04 0.5495 
PLGA/Chi(L) in HBSS 24 111.85 0.0985 108.65 0.0805 91.01 0.2855 
PLGA/Chi(L) in Media  24 52.3 0.5665 111 0.153 93.33 0.271 
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APPENDIX D Standard Curve for Alpha-tocopherol 
Detection by High Performance Liquid Chromatography 
 
Table D-1 Alpha-tocopherol standard curve raw data collected by reverse-phase 
HPLC detection for a concentration range of 20 – 1000 ng 
 
Conc (ug/ mL) Inj Vol (μL) Rep 1 Rep 2 Rep 3 Avg Stdev 
0.1 25 7.18822 7.04351 6.46658 6.899436667 0.381783861 
0.5 
 
 
 
 
0.5 
25 30.9725 30.72056 29.98665 30.55990333 0.512184517 
1 25 65.19831 63.8701 56.50754 61.85865 4.681540251 
2.5 25 167.76172 165.32672 152.45781 161.84875 8.223419107 
5 25 339.80759 334.01062 305.32715 326.3817867 18.46278715 
10 25 683.25348 667.948 616.56866 655.92338 34.93078756 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure D-1: Alpha-tocopherol standard curve for HPLC detection with a regression co-
efficient of 1. 
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APPENDIX E Standard Curve for Lutein by Spectrophotometer 
 
Table E-1 Lutein standard curve raw data collected by spectrophotometer detection 
for a concentration range of 0.25 – 50 ug 
 
Conc (ug/ mL) Absorbance Avg Stdev 
 Rep 1 Rep 2 Rep 3   
0.25 0.024 0.02 0.007 0.017 0.008888194 
0.5 
 
 
 
 
0.5 
0.036 0.028 0.017 0.027 0.009539392 
1 0.07 0.057 0.038 0.055 0.016093477 
10 0.677 0.538 0.415 0.543333333 0.1310814 
25 1.623 1.252 1.015 1.296666667 0.306451192 
50  2.514 2.006 2.26 0.359210245 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure E. 1: Lutein standard curve by spectrophotometer with a regression co-efficient 
of 0.9594 
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APPENDIX F Alpha-tocopherol Entrapped Nanoparticle in Media 
Data  
 
Table F-1 Raw data for stability of entrapped alpha-tocopherol measured by HPLC 
 
PLGA(aT) in Water 
Time Inj Vol Rep 1 Rep 2 Rep 3 
(hr) (uL) Ret 
Time 
AUC ug/ml Ret Time AUC ug/ml Ret 
Time 
AUC ug/ml 
0 25 10.143 133.71
75 
2.065 10.161 94.532 1.469 10.219 143.845 2.219 
4 25 10.169 102.89
9 
1.596 10.133 112.273 1.739 10.157 123.319 1.907 
8 25 10.158 101.53
2 
1.576    10.201 126.084 1.949 
12 25 10.147 101.13
3 
1.570 10.128 112.664 1.745 10.214 84.248 1.313 
24 25 10.112 102.49
8 
1.590 10.185 113.531 1.758 10.161 120.977 1.871 
PLGA(aT) in PBS 
Time Inj Vol Rep 1 Rep 2 Rep 3 
(hr) (uL) Ret 
Time 
AUC ug/ml Ret Time AUC ug/ml Ret 
Time 
AUC ug/ml 
0 25 10.143 113.20
1 
1.753 10.154 100.051 1.553 10.204 141.908 2.190 
4 25 10.135 10.35
44 
1.710 10.134 119.921 1.855 10.138 122.679 1.897 
8 25 10.157 109.16
6 
1.692 10.129 125.211 1.936 10.219 124.994 1.932 
12 25 10.139 108.13
8 
1.676 10.132 121.731 1.883 10.207 80.105 1.250 
24 25 10.111 108.16
1 
1.676 10.171 114.679 1.776 10.164 118.780 1.838 
PLGA(aT) in HBSS 
Time Inj Vol Rep 1 Rep 2 Rep 3 
(hr) (uL) Ret 
Time 
AUC ug/ml Ret Time AUC ug/ml Ret 
Time 
AUC ug/ml 
0 25 10.136 111.96
5 
1.734 10.158 109.264 1.693 10.193 99.278 1.541 
4 25 10.134 107.85
8 
1.672 10.137 117.151 1.813 10.136 118.806 1.838 
8 25 10.154 104.71
6 
1.624 10.171 132.380 2.045 10.221 128.192 1.981 
12 25 10.162 106.45
6 
1.651 10.115 119.006 1.841 10.222 81.806 1.276 
24 25 10.105 106.18
7 
1.646 10.176 116.200 1.799 10.145 122.623 1.896 
PLGA(aT) in Media 
Time Inj Vol Rep 1 Rep 2 Rep 3 
(hr) (uL) Ret 
Time 
AUC ug/ml Ret Time AUC ug/ml Ret 
Time 
AUC ug/ml 
0 25 10.116 112.98
33 
1.750 10.157 108.278 1.678 10.195 113.939 1.764 
4 25 10.15 111.65
8 
1.730 10.157 122.844 1.900 10.138 122.368 1.893 
8 25 10.15 109.25 1.693 10.171 128.569 1.987 10.247 126.639 1.957 
12 25 10.144 113.66
5 
1.760 10.119 122.134 1.889 10.208 80.540 1.256 
24 25 10.105 109.24
3 
1.693 10.166 119.099 1.843 10.156 113.195 1.753 
Table Continued  
  
43 
 
Emulsion (aT) 
Time Inj Vol Rep 1 Rep 2 Rep 3 
(hr) (uL) Ret 
Time 
AUC ug/ml Ret Time AUC ug/ml Ret 
Time 
AUC ug/ml 
0 25 10.124 137.87
8 
2.128 10.177 145.315 2.242 10.189 132.695 2.050 
4 25 10.12 166.93
6 
2.570 10.126 122.508 1.895 10.142 142.081 2.192 
8 25 10.141 135.91
15 
2.099 10.102 135.038 2.085 10.251 162.316 2.500 
12 25 10.139 44.5 2.229 10.108 109.258 1.693 10.206 89.065 1.386 
24 25 10.094 98.488 1.529 10.16 110.415 1.711 10.151 115.776 1.792 
PLGA/Chi(aT) in Water 
Time Inj Vol Rep 1 Rep 2 Rep 3 
(hr) (uL) Ret 
Time 
AUC ug/ml Ret Time AUC ug/ml Ret 
Time 
AUC ug/ml 
0 25 10.122 105.62
3 
1.638 10.146 81.580 1.272 10.19 110.003 1.704 
4 25 10.121 97.75 1.518 10.111 101.722 1.579 10.133 121.798 1.884 
8 25 10.126 98.63 1.532 10.09 121.102 1.873 10.212 120.802 1.869 
12 25 10.142 100.69
9 
1.563 10.103 109.205 1.692 10.195 80.076 1.249 
24 25 10.086 8.658 1.532 10.181 110.227 1.708 10.13 114.272 1.769 
PLGA/Chi(aT) in PBS 
Time Inj Vol Rep 1 Rep 2 Rep 3 
(hr) (uL) Ret 
Time 
AUC ug/ml Ret Time AUC ug/ml Ret 
Time 
AUC ug/ml 
0 25 10.108 104.90
59 
1.627 10.132 116.116 1.797 10.182 108.449 1.681 
4 25 10.123 100.17
7 
1.555 10.112 116.307 1.800 10.13 115.529 1.789 
8 25 10.124 100.41
4 
1.559 10.133 123.576 1.911 10.21 123.080 1.903 
12 25 10.112 106.89
6 
1.657 10.103 117.658 1.821 10.209 76.728 1.198 
24 25 10.086 101.57
8 
1.576 10.167 116.439 1.802 10.111 90.492 1.408 
PLGA/Chi(aT) in HBSS 
Time Inj Vol Rep 1 Rep 2 Rep 3 
(hr) (uL) Ret 
Time 
AUC ug/ml Ret Time AUC ug/ml Ret 
Time 
AUC ug/ml 
0 25 10.123 106.45
38 
1.651 10.143 99.569 1.546 10.187 106.742 1.655 
4 25 10.109 93.249 1.450 10.11 107.407 1.665 10.124 113.032 1.751 
8 25 10.129 84.733 1.320 10.091 99.353 1.543 10.216 115.094 1.782 
12 25 10.104 82.648 1.288 10.111 100.970 1.567 10.198 111.494 1.727 
24 25 10.095 87.966 1.369 10.165 99.821 1.550 10.086 93.744 1.457 
Table Continued  
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PLGA/Chi(aT) in Media  
Time Inj Vol Rep 1 Rep 2 Rep 3 
(hr) (uL) Ret 
Time 
AUC ug/ml Ret Time AUC ug/ml Ret 
Time 
AUC ug/ml 
0 25 10.121 107.95
31 
1.673 10.139 109.114 1.691 10.179 101.931 1.582 
4 25 10.106 96.577 1.500 10.113 98.949 1.536 10.133 107.194 1.662 
8 25 10.133 91.881 1.429 10.072 98.086 1.523 10.197 108.885 1.687 
12 25 10.111 86.136 1.342 10.103 108.085 1.675 10.2 70.070 1.097 
24 25 10.083 69.656 1.091 10.143 115.406 1.787    
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APPENDIX G Lutein Entrapped Nanoparticle in Media Data 
 
Table G-1 Raw data for stability of entrapped lutein measured by spectrophotometer  
 
PLGA(L) in Water 
 Rep 1 Rep 2 Rep 3 
Time (hr) Abs ug/ml Abs ug/ml Abs ug/ml 
0 0.108 1.564 0.102 1.434 0.094 1.261 
4 0.084 1.045 0.102 1.434 0.11 1.607 
8 0.098 1.348 0.09 1.175 0.1 1.391 
24 0.102 1.434 0.1 1.391   
48 0.1 1.391 0.1 1.391 0.092 1.218 
72 0.098 1.348 0.104 1.477 0.052 0.354 
PLGA(L) in PBS 
 Rep 1 Rep 2 Rep 3 
Time (hr) Abs ug/ml Abs ug/ml Abs ug/ml 
0 0.098 1.348 0.08 0.959 0.104 1.477 
4 0.09 1.175 0.092 1.218 0.118 1.780 
8 0.092 1.218 0.09 1.175 0.096 1.305 
24 0.088 1.132 0.096 1.305   
48 0.09 1.175 0.096 1.305 0.076 0.873 
72 0.092 1.218 0.082 1.002 0.072 0.786 
PLGA(L) in HBSS 
 Rep 1 Rep 2 Rep 3 
Time (hr) Abs ug/ml Abs ug/ml Abs ug/ml 
0 0.104 1.477 0.104 1.477 0.102 1.434 
4 0.098 1.348 0.092 1.218 0.094 1.261 
8 0.088 1.132 0.092 1.218 0.096 1.305 
24 0.11 1.607 0.09 1.175   
48 0.096 1.305 0.09 1.175 0.108 1.564 
72 0.092 1.218 0.092 1.218 0.072 0.786 
PLGA(L) in Media 
 Rep 1 Rep 2 Rep 3 
Time (hr) Abs ug/ml Abs ug/ml Abs ug/ml 
0 0.114 1.693 0.116 1.737 0.108 1.564 
4 0.116 1.737 0.118 1.780 0.138 2.212 
8 0.12 1.823 0.098 1.348 0.104 1.477 
24 0.114 1.693 0.11 1.607   
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48 0.124 1.909 0.11 1.607 0.054 0.397 
72 0.044 0.181 0.112 1.650 0.078 0.916 
Emulsion(L) 
 Rep 1 Rep 2 Rep 3 
Time (hr) Abs ug/ml Abs ug/ml Abs ug/ml 
0 0.158 2.644 0.088 1.132 0.164 2.773 
4 0.106 1.521 0.084 1.045 0.152 2.514 
8 0.118 1.780 0.076 0.873 0.148 2.428 
24 0.118 1.780 0.086 1.089   
48 0.084 1.045 0.086 1.089 0 -0.769 
72 0 -0.769 0.07 0.743 0.068 0.700 
PLGA/Chi(L) in Water 
 Rep 1 Rep 2 Rep 3 
Time (hr) Abs ug/ml Abs ug/ml Abs ug/ml 
0 0.156 2.600 0.162 2.730 0.152 2.514 
4 0.124 1.909 0.168 2.860 0.162 2.730 
8 0.154 2.557 0.15 2.471 0.146 2.384 
24 0.138 2.212 0.146 2.384   
48 0.198 3.508 0.146 2.384 0.128 1.996 
72 0.146 2.384 0.152 2.514 0.108 1.564 
PLGA/Chi(L) in PBS 
 Rep 1 Rep 2 Rep 3 
Time (hr) Abs ug/ml Abs ug/ml Abs ug/ml 
0 0.134 2.125 0.154 2.557 0.104 1.477 
4 0.084 1.045 0.12 1.823 0.084 1.045 
8 0.068 0.700 0.112 1.650 0.1 1.391 
24 0.068 0.700 0.108 1.564   
48 0.028 -0.164 0.108 1.564 0.008 -0.596 
72 0.004 -0.683 0.036 0.009 0 -0.769 
PLGA/Chi(L) in HBSS 
 Rep 1 Rep 2 Rep 3 
Time (hr) Abs ug/ml Abs ug/ml Abs ug/ml 
0 0.138 2.212 0.14 2.255 0.178 3.076 
4 0.142 2.298 0.134 2.125 0.138 2.212 
8 0.124 1.909 0.142 2.298 0.18 3.119 
24 0.128 1.996 0.122 1.866   
48 0.12 1.823 0.122 1.866 0.156 2.600 
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72 0.088 1.132 0.13 2.039 0.114 1.693 
PLGA/Chi(L) in Media 
 Rep 1 Rep 2 Rep 3 
Time (hr) Abs ug/ml Abs ug/ml Abs ug/ml 
0 0.168 2.860 0.07 0.743 0.11 1.607 
4 0.152 2.514 0.068 0.700 0.118 1.780 
8 0.168 2.860 0.054 0.397 0.124 1.909 
24 0.156 2.600 0.054 0.397   
48 0.23 4.199 0.054 0.397 0.148 2.428 
72 0.082 1.002 0.058 0.484 0.062 0.570 
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APPENDIX H Initial and Final pH values of Medium 
 
Table H-1 Presents initial pH of mediums without particles present and an average of 
final pH values.   
 
 
 
 
Medium 
 
Initial 
 
Average Final 
   PLGA 
 
PLGA/Chi 
 
Emulsion 
 
Water 
 
5 
 
5.67 
 
5.09 
 
5.5 
 
PBS 
 
7 
 
7.25 
 
6.92  
 
HBSS 
 
7.5 
 
7.67 
 
7.67  
 
Cell Media 
 
8 
 
8 
 
7.25  
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